Onconetix (ONCO) Price to Sales (2024 - 2026)

Onconetix (ONCO) has reported Price to Sales for 3 consecutive years, with 148.03 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales rose 482.22% year-over-year to 148.03 in Q2 2026; TTM through Jun 2026 was 3.92, a 92.31% increase from a year earlier, with the FY2025 full-year figure at 1.79, down 96.92% from the prior year.
• Price to Sales was 148.03 for Q2 2026 at Onconetix, up from 43.65 in the prior quarter.
• Over five years, Price to Sales peaked at 17989.45 in Q2 2024 and troughed at 4.82 in Q4 2025.
• A 3-year average of 3772.94 and a median of 177.27 in 2024 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales plunged 99.86% in 2025 and jumped 482.22% in 2026, its largest moves.
• Over 3 years, Price to Sales stood at 206.5 in 2024, then tumbled by 97.67% to 4.82 in 2025, then jumped by 2972.32% to 148.03 in 2026.
• The last three Price to Sales figures came in at 148.03 (Q2 2026), 43.65 (Q1 2026), and 4.82 (Q4 2025), per Business Quant data.